Stock Events

BioNxt Solutions 

$0.43
3
-$0.02-4.97% Thursday 14:46

Statistics

Day High
0.46
Day Low
0.46
52W High
0.58
52W Low
0
Volume
150
Avg. Volume
1,010
Mkt Cap
33.36M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

28NovConfirmed
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.06
-0.04
-0.02
0
Expected EPS
0
Actual EPS
-0.0149

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BNXTF. It's not an investment recommendation.

About

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Hugh A. D. Rogers B.Sc., LL.B
Country
CA
ISIN
CA0909741062
WKN
000A3D1K3

Listings